Not Available

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$297,532.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
N43CO201000096
Agency Tracking Number:
N43CO201000096
Solicitation Year:
n/a
Solicitation Topic Code:
NCI
Solicitation Number:
n/a
Small Business Information
APOLIFE, INC.
100 RIVER PLACE, SUITE 6800, DETROIT, MI, 48207-
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
044306905
Principal Investigator:
NALINI MOTWANI
(313) 446-2625
nmotwani@apolife.com
Business Contact:
Research Institution:
n/a
Abstract

ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody candidate. ApoLife has expressed Campath genes in yeast system.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government